CSI Market
Sign In | Register

Charles River Laboratories International inc (CRL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRL Annual Balance Sheets →
Tracking balance sheet results across Charles River Laboratories International inc to Jun 28 2025 helps illustrate how Jun 27 2026's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 27 2026)
(Mar 28 2026) (Dec 27 2025) (Sep 27 2025) (Jun 28 2025)
Assets
Cash & cash equivalent192.03
Cash & Short-term Investments192.00
Accounts receivable711.76
Other Receivables83.27
Inventories346.26
Other Current Assets0.00
Prepaid Expense, Current AS100.41
Total Current Assets1,529.11
Equipment/Property/Plant Net2,955.16
Goodwill net3,076.85
Intangible Assets253.17
Long-term investments0.00
Other Assets, Noncurrent0.00
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization1,510.15
Operating Lease Right Of Use Asset317.84
Deferred Income Tax Assets Net88.60
Total Assets7,532.15
Liabilities
Accounts Payable, Current AC140.98
Accrued Liabilities, Current380.10
Long-term Debt and Capital Lease Obligations, Current DE6.63
Other Liabilities, Current314.41
Taxes Payable270.13
Disposal Group, Including Discontinued Operation, Liabilities, Current LI22.50
Total Current Liabilities1,134.75
Long-term debt2,619.99
Total Long-term Debt2,619.99
Financial Instruments, Insurance, Noncurrent15.57
Employee Benefit Plans, Noncurrent71.94
Deferred Tax Liabilities, Net, Noncurrent LI211.14
Other liabilities, Noncurrent590.24
Contract With Customer Liability Current194.33
Deferred Income Tax Liabilities Net81.40
Total Liabilities4,643.62
Stockholders' Equity
Treasury Stock Common Value-209.99
Common Stock Value0.50
Additional Paid In Capital Common Stock1,986.02
Retained Earnings / Accumulated Deficit1,372.30
Accumulated Other Comprehensive Income-195.99
Other Equity-195.99
Common Stockholder's Equity2,803.45
Non-controlling interests & other42.54
Total Stockholder's Equity2,845.99
Liabilities & Stockholder's Equity7,532.15
4 historic quarters locked

Sign in to unlock the full Charles River Laboratories International inc balance sheet history.

Sign In Create Free Account

About Charles River Laboratories International Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260627)
  • Filed with the SEC: August 5, 2026
  • Source: crl-20260627.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001100682-26-000118

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.